Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments

E-ISSN： 1873-4294|16|7|745-776

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.7, 2016-03, pp. : 745-776

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Therapeutic Target Hsp90 and Cancer Hallmarks

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 347-365

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic profiling joins personalized cancer medicine

By Heyn Holger Méndez-González Jesús Esteller Manel

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 5, 2013-06 ,pp. : 473-479

Informa Healthcare

Access to resources Recommend Favorite

The “Epigenetic Code Replication Machinery”, ECREM: A Promising Drugable Target of the Epigenetic Cell Memory

Current Medicinal Chemistry, Vol. 14, Iss. 25, 2007-10 ,pp. : 2629-2641

Bentham Science Publishers

Access to resources Recommend Favorite

NEDD4: A Promising Target for Cancer Therapy

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite

gp130: a promising drug target for cancer therapy

By Xu Shili Neamati Nouri

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1303-1328

Informa Healthcare

Access to resources Recommend Favorite